Dr. Vincent Lopez Rowe, MD

Dr. Rowe practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Rowe's NPI, 1396777215, was assigned on July 7, 2006. Dr. Rowe graduated from Keck School of Medicine of USC in 1991. Dr. Rowe holds California license G76069.

Dr. Rowe's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Rowe's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Rowe is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Rowe to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowe practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rowe's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Rowe is board certified in surgery by the American Board of Surgery. Dr. Rowe is licensed in California.

Dmand AI lists blood vessel access for dialysis, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Rowe treats.

CMS data shows 222 Medicare services from Dr. Rowe across 5 procedure codes in 2024, for 165 Medicare patients. Medicare paid $34,143 for them.

CMS counts 165 Medicare patients who saw Dr. Rowe in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rowe's median patient age at 63, with 55% women.

In 2024, Dr. Rowe wrote 18 Medicare Part D claims. 83% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $250 in total drug cost. In 2016, CMS named 34 claims across 3 drugs.

Dr. Rowe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rowe as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Rowe, published from 2011 to 2025. 2019 was the busiest year, with 4. Dr. Rowe's most frequent co-authors are Sung Wan Ham, MD, Sukgu Michael Han, MD and Fred A. Weaver, MD.

CMS Open Payments shows 179 general payments to Dr. Rowe from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. CVRx, Inc. paid the most, $7,192.

Dmand AI lists 4 awards for Dr. Rowe, most recently Top Doctors:LA Area in 2013.

Dr. Rowe graduated from Keck School of Medicine of USC in 1991. Dr. Rowe is a member of ACS and SVS.

Dr. Rowe is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.